Elizabeth Christie
Post-doctoral researcher in the Cancer Genetics an
Medicine
Peter MacCallum Cancer Centre
Australia
Biography
Dr Elizabeth Christie is a post-doctoral researcher in the Cancer Genetics and Genomics (Bowtell) Laboratory. Dr Christie's current research interests are understanding the genomics underlying acquired chemoresistance in ovarian cancer, with a particular focus on utilising next-generation sequencing of circulating DNA as a biomarker.
Research Interest
OVARIAN CANCER GENETICS
Publications
-
A community-based model of rapid autopsy in end-stage cancer patients. Nature Biotechnology. 34. 2016
-
Reversion of BRCA1/2 Germline Mutations Detected in Circulating Tumor DNA From Patients With High-Grade Serous Ovarian Cancer. Journal of Clinical Oncology. 35. 2017
-
EIF1AX and NRAS Mutations Co-occur and Cooperate in Low-Grade Serous Ovarian Carcinomas. 2017
